Literature DB >> 26432457

The effects of cryopreservation on angiogenesis modulation activity of human amniotic membrane.

Ghasem Yazdanpanah1, Ghodsieh Paeini-Vayghan1, Samira Asadi1, Hassan Niknejad2.   

Abstract

Amniotic membrane (AM), as the innermost layer of placenta, has side dependent effects on the angiogenesis. Cryopreservation is a necessary process to avoid the challenging problems of fresh tissues; a procedure which makes the AM ready-to-use. Since the cryopreservation can influence the AM characteristics for experimental and clinical purposes, in this study the effects of cryopreservation were evaluated on angiogenesis modulation activity of the AM compared to fresh tissues in an animal model. The AM was implanted mesenchymal side up or epithelial side up in a rat dorsal skinfold chamber. The length and number of branches of formed capillaries were measured via intravital microscopy after 7 days. The amount of IL-8 (interleukin-8) and TIMP-2 (Tissue Inhibitor of Matrix Metalloproteinase-2) as two factors in amniotic cells which have great impacts on angiogenesis were evaluated using ELISA assay. The epithelial surface of cryopreserved AM had inhibitory effects on vessel formation. The cryopreserved amniotic mesenchymal side increased the vessel length and sprout. The result of cryopreserved AM on angiogenesis was similar to that of fresh tissues. The levels of IL-8 and TIMP-2 in cryopreserved samples were significantly less than fresh AMs which shows that angio-modulatory properties are not limited to the effects of amnion epithelial and mesenchymal stem cells and the other components such as extracellular matrix may contribute in angio-modulatory effects. These promising results show that inducing and inhibitory effects of the AM, which make it an appropriate candidate for different clinical situations, were maintained after cryopreservation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amniotic membrane; Angiogenesis; Cryopreservation; Interleukin-8; TIMP-2

Mesh:

Year:  2015        PMID: 26432457     DOI: 10.1016/j.cryobiol.2015.09.008

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  6 in total

Review 1.  Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

Authors:  Hoda Elkhenany; Ahmed Shekshek; Mohamed Abdel-Daim; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Induction of antimicrobial peptides secretion by IL-1β enhances human amniotic membrane for regenerative medicine.

Authors:  Fatemeh A Tehrani; Khashayar Modaresifar; Sara Azizian; Hassan Niknejad
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

3.  Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.

Authors:  Mohsen Abbasi-Kangevari; Seyyed-Hadi Ghamari; Fahimeh Safaeinejad; Soheyl Bahrami; Hassan Niknejad
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

Review 4.  Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury.

Authors:  Yu-Ting Song; Peng-Cheng Liu; Jie Tan; Chen-Yu Zou; Qian-Jin Li; Jesse Li-Ling; Hui-Qi Xie
Journal:  Stem Cell Res Ther       Date:  2021-10-30       Impact factor: 6.832

Review 5.  Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.

Authors:  Sepehr Shafiee; Siavash Shariatzadeh; Ali Zafari; Alireza Majd; Hassan Niknejad
Journal:  Front Bioeng Biotechnol       Date:  2021-11-25

6.  Clinical application of decellularized and lyophilized human amnion/chorion membrane grafts for closing post-laryngectomy pharyngocutaneous fistulas.

Authors:  Zurab Kakabadze; Konstantine Mardaleishvili; George Loladze; Ivane Javakhishvili; Konstantine Chakhunasvili; Lika Karalashvili; Natia Sukhitashvili; Gocha Chutkerashvili; Ann Kakabadze; David Chakhunasvili
Journal:  J Surg Oncol       Date:  2016-01-21       Impact factor: 3.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.